| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/21/2005 | US20050158423 Method of improving food fermentation procedures |
| 07/21/2005 | US20050158373 Method and carrier complexes for delivering molecules to cells |
| 07/21/2005 | US20050158372 Immunoliposome-nucleic acid amplification (ILNAA) assay |
| 07/21/2005 | US20050158345 ABC (ATP-binding cassette) transporters; polynucleotides, expression vectors, transformed host cells and antibodies; use in vaccination |
| 07/21/2005 | US20050158344 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 07/21/2005 | US20050158343 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 07/21/2005 | US20050158342 Multi plasmid system for the production of influenza virus |
| 07/21/2005 | US20050158340 Recombinant RSV virus expression systems and vaccines |
| 07/21/2005 | US20050158338 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s); vaccines |
| 07/21/2005 | US20050158335 Polynucleotides from a gene cluster encoding pilin polypeptides; treating or immunizing against infections such as otitis media; antibodies, assays |
| 07/21/2005 | US20050158327 Interrupting the interaction of intercellular adhesion molecule-1 and respiratory syncytial virus for prevention and treatment of infection |
| 07/21/2005 | US20050158321 Drug screening; for methotrexate resistant patients |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158315 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 07/21/2005 | US20050158312 Related to the carboxylate transporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/21/2005 | US20050158310 Via modulating insulin receptor signaling in adipocyte tissue; transgenic/knockout animal; RNA interference |
| 07/21/2005 | US20050158305 Monoclonal antibody for treatment of cancer, autoimmune diseases and rheumatoid arthritis; complementarity determining regions |
| 07/21/2005 | US20050158283 Improving adenoviral yields in cell culture systems via maintaining infection temperature below 37 degrees; gene therapy and hetelogous gene transfer; bioreactors |
| 07/21/2005 | US20050158282 epidermal growth factor (EGF) producing Lactococcus lactis and Lactobacillus casei ( lactic acid bacterium); useful to treat Short Bowel Syndrome; increase intestinal villi height |
| 07/21/2005 | US20050158281 vascular permeability agents (VPAs), such as VEGF, used in conjunction with adeno-associated virus(AVV) a nucleic acid viral vectors; nucleic cid sequences encoding Igf-1( insulin like growth factor-1) and dystrophin or dystrophin-like proteins; muscular disorders |
| 07/21/2005 | US20050158279 Administering a negative-strand RNA viral vector (sendai virus) containing FGF-1 or FGF-5 (fibroblast growth factors) as a foreign gene to animals; gene therapy |
| 07/21/2005 | US20050158278 Means and methods for the production of adenovirus vectors |
| 07/21/2005 | US20050158277 Method to genetate non virulent microorganisms from pathogenic ones through permanent genetic modification of their biological membrane for vaccine production |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | US20050158242 Detecting presence of selected cancer by measuring levels of Cancer Specific Genes(CSG) in cells, tissues or bodily fluids and comparing levels with levels of CSG from normal human control, wherein change in measured levels is associated with presence of selected cancer; gynecologic and lung cancers |
| 07/21/2005 | US20050158241 Novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 07/21/2005 | US20050157915 Method and apparatus for providing a bioinformatics database |
| 07/21/2005 | DE10361917A1 In vitro transfection of cells, useful e.g. in animal tests and for human applications, comprises centrifuging the cells with active agents, preferably packaged in liposomes |
| 07/21/2005 | DE10201463B4 Reaktionsgefäß zur Durchführung von Array-Verfahren Reaction vessel for carrying out array method |
| 07/21/2005 | DE102004045139A1 Dendrimer-basierte DNA-Extraktionsverfahren und Biochips Dendrimer-based DNA extraction procedure and biochips |
| 07/21/2005 | CA2592891A1 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 07/21/2005 | CA2553211A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer |
| 07/21/2005 | CA2552729A1 Amylase |
| 07/21/2005 | CA2552590A1 Interleukin-12 targeted to oncofoetal fibronectin |
| 07/21/2005 | CA2552188A1 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | CA2551877A1 Neutralizing epitope-based growth enhancing vaccine |
| 07/21/2005 | CA2551484A1 Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins |
| 07/21/2005 | CA2551131A1 Novel recombinant proteins with n-terminal free thiol |
| 07/21/2005 | CA2550854A1 Membranes incorporating recognition moieties |
| 07/21/2005 | CA2550800A1 Methods to produce variant glycolipid acyltransferases and variant glycolipid acyltransferases with enhanced activity towards glycolipids |
| 07/21/2005 | CA2550642A1 Oligonucleotide compound and method for treating nidovirus infections |
| 07/21/2005 | CA2549532A1 Bioluminescent assays and cells useful therein |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/21/2005 | CA2540711A1 Method of producing sterile plant, plant obtained by using the same and use thereof |
| 07/20/2005 | EP1555328A2 Recombinant library screening methods |
| 07/20/2005 | EP1555323A2 Ph sensitive mutants of GFP for optically detecting changes in cellular microenvironments |
| 07/20/2005 | EP1555321A1 CCaMK involved in nodulation and endomycorrhization |
| 07/20/2005 | EP1555320A2 Expression system derived from the lipase regulation cascade of Pseudomonas alcaligenes |
| 07/20/2005 | EP1555319A2 Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems |
| 07/20/2005 | EP1555318A2 Hematopoietic cytokine receptor |
| 07/20/2005 | EP1555317A1 Synthetic genes and genetic constructs comprising the same |
| 07/20/2005 | EP1555316A2 Antigen library immunization |
| 07/20/2005 | EP1555315A1 Protein synthesis system using xenopus oocyte extract |
| 07/20/2005 | EP1555314A2 Enzymes and detergent compositions |
| 07/20/2005 | EP1555270A1 HCV NS3 proteins and nucleic acids |
| 07/20/2005 | EP1554931A1 Means for in vitro activating cell nuclei |
| 07/20/2005 | EP1554585A1 Reporter module molecules having active ion channel activity |
| 07/20/2005 | EP1554406A1 Polynucleotide sequence variants |
| 07/20/2005 | EP1554402A2 Real-time detection of nucleic acid reactions |
| 07/20/2005 | EP1554401A2 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 07/20/2005 | EP1554398A2 Apparatus and method for preparative scale purification of nucleic acids |
| 07/20/2005 | EP1554392A2 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
| 07/20/2005 | EP1554389A2 Method for making recombinant proteins |
| 07/20/2005 | EP1554388A1 Transgenic expression cassettes for the expression of nucleic acids in plant blooms |
| 07/20/2005 | EP1554387A2 Plastid transformation |
| 07/20/2005 | EP1554386A2 Single promoter system for making sirna expression cassettes and expression libraries using a polymerase primer hairpin linker |
| 07/20/2005 | EP1554385A2 Calcineurin-like human phoshphoesterase |
| 07/20/2005 | EP1554384A1 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins , and method of manufacturing recombinant fabs |
| 07/20/2005 | EP1554383A1 Recombinant mva strains as potential vaccines against p. falciparum malaria |
| 07/20/2005 | EP1554382A1 Gpr54 knock-out mammals and screening methods using them |
| 07/20/2005 | EP1554381A2 Post transcriptional silencing by short interfering rnas |
| 07/20/2005 | EP1554379A2 Sesquiterpene synthases and methods of use |
| 07/20/2005 | EP1554378A2 Proteases producing an altered immunogenic response and methods of making and using the same |
| 07/20/2005 | EP1554377A2 Thermostable reverse transcriptases and uses thereof |
| 07/20/2005 | EP1554376A2 Soluble rna polymerase protein and methods for the use thereof |
| 07/20/2005 | EP1554375A2 Adenovirus expressing genes in reverse order and use thereof |
| 07/20/2005 | EP1554372A2 Natural promoters for gene expression in c1 metabolizing bacteria |
| 07/20/2005 | EP1554313A1 Regulation of the cre recombinase using a dissociation/re-association system of said recombinase |
| 07/20/2005 | EP1554312A2 Neutralizing antibodies against gdf-8 and uses therefor |
| 07/20/2005 | EP1554310A1 Epididymis-specific gene as potential contraceptive target |
| 07/20/2005 | EP1554308A2 Glucagon-like peptide - 2 variants |
| 07/20/2005 | EP1554307A2 Antagonists il-15 |
| 07/20/2005 | EP1554302A2 Methods and dna constructs for high yield production of polypeptides |
| 07/20/2005 | EP1554301A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 07/20/2005 | EP1553983A2 New settings for recombinant adenoviral-based vaccines |
| 07/20/2005 | EP1553978A2 Interacting site for gp41 on gp120 of hiv-1 |
| 07/20/2005 | EP1553977A2 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 07/20/2005 | EP1553976A2 Hiv envelope-cd4 complexes and hybrids |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553966A2 Human papillomavirus polypeptides and immunogenic compositions |
| 07/20/2005 | EP1553960A1 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1527194A4 Nucleic acid reactions using labels with different redox potentials |
| 07/20/2005 | EP1513950A4 Application of cantilevers in nucleic acid sequencing |
| 07/20/2005 | EP1463808A4 High fidelity dna polymerase compositions and uses therefor |
| 07/20/2005 | EP1425416A4 A high throughput method for identification of sequence tags |
| 07/20/2005 | EP1421095A4 Assay for detection of human parvovirus b19 nucleic acid |
| 07/20/2005 | EP1392105A4 Tobacco biomass utilization |
| 07/20/2005 | EP1386001A4 Kits and methods for assessing oxidative stress |
| 07/20/2005 | EP1373545A4 Mch1r deficient mice |